DempoChem Logo
  1. HomeHome
  2. /ProductsProducts
  3. /Bioactive CompoundsBioactive Compounds
  4. /Protein Kinase TargetsProtein Kinase Targets
  5. /SrcSrc
  6. /tert-butyl (4-(4-amino-1-(2-(4-(dimethylamino)piperidin-1-yl)ethyl)-1H-pyrazolo(3,4-d)pyrimidin-3-yl)-2-methoxyphenyl)carbamateCAS 1914078-41-3
Chemical structure of CAS 1914078-41-3

tert-butyl (4-(4-amino-1-(2-(4-(dimethylamino)piperidin-1-yl)ethyl)-1H-pyrazolo(3,4-d)pyrimidin-3-yl)-2-methoxyphenyl)carbamate

In Stock•Starting at $76 for 1 mg•Purity ≥ 98%
CAS No.1914078-41-3
MDL No.N/A
MFC26H38N8O3
MW510.60
InChI KeyGMPQGWXPDRNCBL-UHFFFAOYSA-N
CUSTOM SYNTHESISPRECLINICAL SUPPORT→

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
1 mg98%$76In Stock
5 mg98%$121In Stock
25 mg98%$386In Stock
50 mg98%$614In Stock
100 mg98%$1000In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.1914078-41-3
Product Nametert-butyl (4-(4-amino-1-(2-(4-(dimethylamino)piperidin-1-yl)ethyl)-1H-pyrazolo(3,4-d)pyrimidin-3-yl)-2-methoxyphenyl)carbamate
Heavy Atom Count37Rotatable Bond Count7
Atom Stereo Count0Bond Stereo Count0
HBA10HBD2
TPSA123.660 ŲCharge0
Exact Mass510.30669Complexity1242.58
pKa7.130XLogP3.457

Related Articles

Studies related to this compound and its mechanism of action

The SRC family kinase inhibitor NXP900 demonstrates potent antitumor activity in squamous cell carcinomas.

The Journal of biological chemistry • Vol. 300, Issue 9 • 2024
PMID: 39089584PMC: PMC11388391DOI: 10.1016/j.jbc.2024.107615

Rapid Discovery and Structure-Activity Relationships of Pyrazolopyrimidines That Potently Suppress Breast Cancer Cell Growth via SRC Kinase Inhibition with Exceptional Selectivity over ABL Kinase.

Journal of medicinal chemistry • Vol. 59, Issue 10 • 2016
PMID: 27115835PMC: PMC4885109DOI: 10.1021/acs.jmedchem.6b00065

Documentation

Similar Products

  • Ibrutinib

    CAS No.936563-96-1

  • PCI-32765 Racemate

    CAS No.936563-87-0

  • Jak3/btk-IN-7

    CAS No.2844387-16-0

  • (R)-3-(3-(4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)-3-oxopropyl acrylate

    CAS No.2244619-11-0

  • 1-[3-[4-Amino-3-[4-(3-ethynylphenoxy)phenyl]pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]prop-2-en-1-one

    CAS No.1621002-24-1

  • Atuzabrutinib

    CAS No.1581714-49-9

Your Partner for
Complex Chemistry
logo
  • About Us
  • Perspectives
  • Products
  • Contact
  • Preclinical Development
  • Technologies
  • Custom Synthesis
Ready to start your project?

Provide your target molecule or project specifications to align on a tailored development and scale-up pathway with our scientific team.

START A PROJECT
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
logo

All products are supplied strictly for research and development use only and are not intended for human or veterinary administration, diagnostic use, or therapeutic use. Preclinical and related services are provided solely for research and development purposes and do not constitute clinical diagnosis, treatment, or veterinary care.

©2026 DempoChem. All Rights Reserved.
DHLFedExUPSPostNL
CLIENT PORTAL|TERMS AND CONDITIONS|PRIVACY POLICY|
  • Products
    • CDMO Compounds
    • API & Candidates
  • Services
    CDMO & Manufacturing
    • Custom Synthesis
    • Process Development
    • Lab To Pilot
    • Commercialization
    • Generic APIs
    CRO
    • Preclinical
    • Pharmacology & Efficacy
    • DMPK & Bioanalysis
    • Toxicology & Safety
    • Disease Models
    Technologies
    • High-Potent
    • Chiral Synthesis
    • Cloud Synthesis
    • Fermentation
    • Flow Chemistry
    • Biocatalysis
    Support
    • Regulatory Support
    • Supply Chain Solutions
  • About
  • Perspectives
  • Contact